Melanoma Bridge 2023
M

Expectations, Concerns, and The Unknown: A SITC Perspective on Survivorship Following Immune Checkpoint Inhibitor Therapy for Patients With Cancer

By Melanoma Bridge 2023 FEATURING Marc Ernstoff
By Melanoma Bridge 2023 FEATURING Marc Ernstoff
38 views
December 28, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
28:21
Houston Methodist Hospital

Palliative Medicine in Cancer Patients

Feat. E. De Leon
09:28
Yale Cancer Center

The Future of Lung Cancer Care

Feat. M. Davies
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
29:43
Michigan Medicine

GI and Hepatic Complications of Cancer Immunotherapy

Feat. R. Fontana
10:07
Oncology Data Advisor

The Importance of Exercise for Cancer Survivorship

Feat. N. Seetharamu
23:38
2023 West Oncology Conference

Improving the Quality of Life for Head & Neck Cancer Survivors: …

Feat. B. Murphy
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
04:04
Dana-Farber Cancer Institute

Metastatic Disease Survivors - mBC Series

Feat. H. Burstein
27:49
Yale Cancer Center

Exercise as Standard of Care for Breast Cancer

Feat. M. Irwin, T. Sanft
40:13
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Feat. R. C. Lynch
19:36
Dana-Farber Cancer Institute

Hot Topics in Nutrition: A Comparison of the Blue Zone Diet and Canc…

Feat. J. Bosworth
20:14
Total Health

Sexual Health and Cancer

Feat. A. Siston
21:45
International Congress on Cancer Metastasis

Immunotherapy and Targeted Therapy for Personalized Cancer Treatment

Feat. K. Kim
13:16
Vanderbilt University Medical Center (VUMC)

Nutrition Considerations in Survivorship

Feat. S. Pavelka
98:16
Scripps Health

Natural Medicines in Cancer Survivorship Care

Feat. D. Leopold
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
42:09
Masonic Cancer Center, University of Minnesota

Hormone Deficiencies After Cancer: Diagnosis, Risks, & Benefits …

Feat. B. Miller
21:48
Houston Methodist Hospital

Tumor-Infiltrating Lymphocytes for Clinicians

Feat. S. Ganguly
08:36
i3 Health

Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence…

Feat. A. Sacco
37:04
Nebraska Oncology Society

Survivorship After Transplant and CAR-T for Hematologic Malignancies

Feat. N. Ahmed